BIONIK Laboratories Corp. Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Tables)

3 Months Ended

Jun. 30, 2022


	June 30, 2022			March 31, 2022
	Number of shares	$		Number of shares	$
Exchangeable Shares
Balance beginning of period	112,440	$	113	112,440	$	113
Converted into common shares	—		—	—		—
Balance at end of period	112,440		113	112,440		113
Common Shares
Balance at beginning of the period	6,767,114		6,766	5,589,375		5,589
Shares issued on conversion of loans (a)	—		—	947,602		947
Shares issued for in lieu of services (b)	—		—	50,000		50
Options exercised in conjunction with 2021 Notes (c)	—		—	180,137		180
Balance at end of the period	6,767,114		6,766	6,767,114		6,766
Total Shares	6,879,554	$	6,879	6,879,554	$	6,879